Part of Vanderbilt DRTC's Weekly Seminar Series 


Record History
Added on September 6, 2017 at 2:46 PM by Kimber, Jessica
Modified on December 4, 2017 at 2:28 PM by Kimber, Jessica
Shared with (contributions)
DRTC: DRTC Friday Seminar Series Master

Meeting Details

Start Date / Time December 8, 2017 at 12:00 PM
End Date / Time December 8, 2017 at 1:00 PM
Duration 1 hour(s)
Location 206 Preston Research Building
Presenter Name Matt Luther, MD, Vanderbilt University
Presentation Title Epoxyeicosatrienoic Acid, CYP2C Metabolism, and Insulin Resistance in Humans
Status This meeting has already occurred

Meeting Agenda/Notes

Matt Luther, MD
Assistant Professor of Medicine
Clinical Pharmacology
Vanderbilt University

 Dr. Luther will discuss his translational studies in mice and in humans that test how the renin-angiotensin-aldosterone system and CYP450 monooxygenase system can impair insulin action, insulin secretion, and vascular function. He will also discuss their work in developing novel non-invasive biomarkers in humans to assess renal epithelial function. 

Hosted by Sean Davies, PhD